36-month cost-utility analysis of antipsychotic treatments in patients with schizophrenia in the pan-European soho (schizophrenia outpatient health outcomes) study

被引：0
|
作者：
Windmeijer, F.
Brown, J.
Novick, D.
Hong, J.
Knapp, M.
Kontodimas, S.
Ratcliffe, M.
机构：
[1] Univ Bristol, Lilly Res Ctr Ltd, Bristol GU20 6PH, England
[2] Eli Lilly & Co, Windlesham, Surrey, England
[3] London Sch Econom, London, England
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)68776-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A78 / A79
页数：2
相关论文
共 50 条
  • [41] Comparison of olanzapine and quetiapine antipsychotic treatments for schizophrenia: Six-month results from the three-year intercontinental schizophrenia outpatient health outcomes (IC-SOHO) observational study
    Boland, J
    O'Halloran, RA
    Dossenbach, M
    Levitt, L
    Enatescu, V
    Simon, L
    Janu, L
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 274 - 274
  • [42] Comparison of olanzapine and quetiapine antipsychotic treatments of schizophrenia: 6-month results from the 3-year intercontinental schizophrenia outpatient health outcomes (IC-SOHO) observational study
    Morrison, S
    O'Halloran, RA
    Boland, J
    Dossenbach, M
    Mahuad, R
    Gastiaburu, CO
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2003, 37 : A12 - A13
  • [43] Factors associated to risk of relapse in schizophrenia: 36 month results from the schizophrenia outpatients health outcomes (SOHO) study
    Novick, D
    Haro, JM
    Suarez, D
    Ratcliffe, M
    SCHIZOPHRENIA RESEARCH, 2006, 81 : 60 - 60
  • [44] Reply to Letter on: Incidence of Extrapyramidal Symptoms and Tardive Dyskinesia in Schizophrenia 36-Month Results From the European SOHO Study
    Novick, Diego
    Maria Haro, Joseph
    Bertsch, Jordan
    Haddad, Peter M.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2011, 31 (03) : 384 - 385
  • [45] Antipsychotic prescription patterns in outpatient settings: 24-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study
    Bitter, Istvan
    Treuer, Tamas
    Dyachkova, Yulia
    Martenyi, Ferenc
    McBride, Margaret
    Ungvari, Gabor S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 (03) : 170 - 180
  • [46] Pharmacological treatment and other predictors of treatment outcomes in previously untreated patients with schizophrenia: results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study
    Gasquet, I
    Haro, JM
    Novick, D
    Edgell, ET
    Kennedy, L
    Lepine, JP
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2005, 20 (04) : 199 - 205
  • [47] Use of concomitant medication with antipsychotic treatment in outpatients with schizophrenia: Results from the European Schizophrenia Outpatients Health Outcomes (SOHO) study
    Novick, D
    Bousono, M
    Suarez, D
    Olivares, JM
    Montejo, AL
    Haro, JM
    Edgell, ET
    Ratcliffe, M
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2005, 29 (06): : 970 - 980
  • [48] Long-term patterns of antipsychotic treatment of outpatients with schizophrenia: 24-Month results from the intercontinental schizophrenia outpatient health outcomes (IC-SOHO) study
    Bitter, I.
    Treuer, T.
    Dyachkova, Y.
    West, T.
    Martenyi, F.
    McBride, M.
    Ungvari, G.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S150 - S150
  • [49] Clinical consequences of switching from olanzapine to risperidone and vice versa in outpatients with schizophrenia: 36-month results from the worldwide schizophrenia outpatients health outcomes (W-SOHO) study
    Hong, Jihyung
    Novick, Diego
    Brugnoli, Roberto
    Karagianis, Jamie
    Dossenbach, Martin
    Haro, Josep Maria
    BMC PSYCHIATRY, 2012, 12
  • [50] Clinical consequences of switching from olanzapine to risperidone and vice versa in outpatients with schizophrenia: 36-month results from the worldwide schizophrenia outpatients health outcomes (W-SOHO) study
    Jihyung Hong
    Diego Novick
    Roberto Brugnoli
    Jamie Karagianis
    Martin Dossenbach
    Josep Maria Haro
    BMC Psychiatry, 12
12345